File Download
 
Links for fulltext
(May Require Subscription)
  • Find via
 
Supplementary

Conference Paper: Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year
  • Basic View
  • Metadata View
  • XML View
TitlePhase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year
 
AuthorsGane, E
Lai, CL
Liaw, YF
Thongsawat, S
Wang, YM
Cheng, Y
Heathcote, J
Rasenack, J
Bzowej, N
Naoumov, N
Chao, G
Fielman, B
Brown, N
 
Issue Date2006
 
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
 
CitationJournal of Hepatology, v. 44 n. Suppl 2, p. S183-184 [How to Cite?]
 
ISSN0168-8278
2013 Impact Factor: 10.401
 
DC FieldValue
dc.contributor.authorGane, E
 
dc.contributor.authorLai, CL
 
dc.contributor.authorLiaw, YF
 
dc.contributor.authorThongsawat, S
 
dc.contributor.authorWang, YM
 
dc.contributor.authorCheng, Y
 
dc.contributor.authorHeathcote, J
 
dc.contributor.authorRasenack, J
 
dc.contributor.authorBzowej, N
 
dc.contributor.authorNaoumov, N
 
dc.contributor.authorChao, G
 
dc.contributor.authorFielman, B
 
dc.contributor.authorBrown, N
 
dc.date.accessioned2010-09-25T20:37:56Z
 
dc.date.available2010-09-25T20:37:56Z
 
dc.date.issued2006
 
dc.identifier.citationJournal of Hepatology, v. 44 n. Suppl 2, p. S183-184 [How to Cite?]
 
dc.identifier.epage184
 
dc.identifier.hkuros122318
 
dc.identifier.issn0168-8278
2013 Impact Factor: 10.401
 
dc.identifier.issueSuppl 2
 
dc.identifier.openurl
 
dc.identifier.spage183
 
dc.identifier.urihttp://hdl.handle.net/10722/102618
 
dc.identifier.volume, v. 44 n. Suppl 2
 
dc.languageeng
 
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
 
dc.relation.ispartofJournal of Hepatology
 
dc.rightsJournal of Hepatology. Copyright © Elsevier BV.
 
dc.titlePhase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Gane, E</contributor.author>
<contributor.author>Lai, CL</contributor.author>
<contributor.author>Liaw, YF</contributor.author>
<contributor.author>Thongsawat, S</contributor.author>
<contributor.author>Wang, YM</contributor.author>
<contributor.author>Cheng, Y</contributor.author>
<contributor.author>Heathcote, J</contributor.author>
<contributor.author>Rasenack, J</contributor.author>
<contributor.author>Bzowej, N</contributor.author>
<contributor.author>Naoumov, N</contributor.author>
<contributor.author>Chao, G</contributor.author>
<contributor.author>Fielman, B</contributor.author>
<contributor.author>Brown, N</contributor.author>
<date.accessioned>2010-09-25T20:37:56Z</date.accessioned>
<date.available>2010-09-25T20:37:56Z</date.available>
<date.issued>2006</date.issued>
<identifier.citation>Journal of Hepatology, v. 44  n. Suppl 2, p. S183-184</identifier.citation>
<identifier.issn>0168-8278</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/102618</identifier.uri>
<language>eng</language>
<publisher>Elsevier BV. The Journal&apos;s web site is located at http://www.elsevier.com/locate/jhep</publisher>
<relation.ispartof>Journal of Hepatology</relation.ispartof>
<rights>Journal of Hepatology. Copyright &#169; Elsevier BV.</rights>
<title>Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year</title>
<type>Conference_Paper</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=0168-8278&amp;volume=44 &amp;issue=Suppl 2&amp;spage=S183&amp;epage=184&amp;date=2006&amp;atitle=Phase+III+comparison+of+telbivudine+vs+lamivudine+in+HBeAg-positive+patients+with+chronic+hepatitis+B:+Efficacy,+safety,+and+predictors+of+response+at+1+year</identifier.openurl>
<identifier.hkuros>122318</identifier.hkuros>
<identifier.volume>, v. 44  n. Suppl 2</identifier.volume>
<identifier.issue>Suppl 2</identifier.issue>
<identifier.spage>183</identifier.spage>
<identifier.epage>184</identifier.epage>
</item>